ATE370947T1 - 7-((1,4)dioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren liganden - Google Patents
7-((1,4)dioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren ligandenInfo
- Publication number
- ATE370947T1 ATE370947T1 AT04726119T AT04726119T ATE370947T1 AT E370947 T1 ATE370947 T1 AT E370947T1 AT 04726119 T AT04726119 T AT 04726119T AT 04726119 T AT04726119 T AT 04726119T AT E370947 T1 ATE370947 T1 AT E370947T1
- Authority
- AT
- Austria
- Prior art keywords
- dioxan
- adenosine receptors
- benzothiazole derivatives
- receptors ligands
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03008038 | 2003-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE370947T1 true ATE370947T1 (de) | 2007-09-15 |
Family
ID=33104055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04726119T ATE370947T1 (de) | 2003-04-14 | 2004-04-07 | 7-((1,4)dioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren liganden |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6872833B2 (de) |
| EP (1) | EP1615919B1 (de) |
| JP (1) | JP4426569B2 (de) |
| KR (1) | KR100700422B1 (de) |
| CN (1) | CN100447140C (de) |
| AR (1) | AR043845A1 (de) |
| AT (1) | ATE370947T1 (de) |
| AU (1) | AU2004228193B2 (de) |
| BR (1) | BRPI0409402A (de) |
| CA (1) | CA2520852C (de) |
| CL (1) | CL2004000761A1 (de) |
| CO (1) | CO5640107A2 (de) |
| DE (1) | DE602004008447T2 (de) |
| ES (1) | ES2291868T3 (de) |
| MX (1) | MXPA05011102A (de) |
| NO (1) | NO20054794L (de) |
| RU (1) | RU2005135154A (de) |
| TW (1) | TW200427685A (de) |
| WO (1) | WO2004089949A1 (de) |
| ZA (1) | ZA200508180B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1796673A2 (de) * | 2004-09-23 | 2007-06-20 | Reddy US Therapeutics, Inc. | Neue pyrimidin-verbindungen, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen |
| US7756037B2 (en) * | 2006-08-14 | 2010-07-13 | Cisco Technology, Inc. | Oversubscription of guaranteed bandwidth |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
| US9243001B2 (en) | 2013-03-15 | 2016-01-26 | Epizyme, Inc. | Substituted benzene compounds |
| AU2014254392B2 (en) * | 2013-03-15 | 2018-05-24 | Epizyme, Inc. | Substituted benzene compounds |
| RS64035B1 (sr) * | 2017-08-01 | 2023-04-28 | Merck Patent Gmbh | Derivati tiazolopiridina kao antagonisti receptora adenozina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0112395A (pt) * | 2000-06-21 | 2003-07-08 | Hoffmann La Roche | Derivados de benzotiazol |
| AU2002226634B2 (en) * | 2001-03-30 | 2007-01-25 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US6620811B2 (en) | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| US6734179B2 (en) | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
-
2004
- 2004-03-30 US US10/812,736 patent/US6872833B2/en not_active Expired - Fee Related
- 2004-04-07 KR KR1020057019469A patent/KR100700422B1/ko not_active IP Right Cessation
- 2004-04-07 DE DE602004008447T patent/DE602004008447T2/de not_active Expired - Lifetime
- 2004-04-07 MX MXPA05011102A patent/MXPA05011102A/es active IP Right Grant
- 2004-04-07 CA CA2520852A patent/CA2520852C/en not_active Expired - Fee Related
- 2004-04-07 ES ES04726119T patent/ES2291868T3/es not_active Expired - Lifetime
- 2004-04-07 TW TW093109634A patent/TW200427685A/zh unknown
- 2004-04-07 RU RU2005135154/04A patent/RU2005135154A/ru not_active Application Discontinuation
- 2004-04-07 CN CNB2004800098019A patent/CN100447140C/zh not_active Expired - Fee Related
- 2004-04-07 JP JP2006505050A patent/JP4426569B2/ja not_active Expired - Fee Related
- 2004-04-07 AU AU2004228193A patent/AU2004228193B2/en not_active Ceased
- 2004-04-07 WO PCT/EP2004/003734 patent/WO2004089949A1/en active IP Right Grant
- 2004-04-07 AT AT04726119T patent/ATE370947T1/de active
- 2004-04-07 EP EP04726119A patent/EP1615919B1/de not_active Expired - Lifetime
- 2004-04-07 BR BRPI0409402-6A patent/BRPI0409402A/pt not_active IP Right Cessation
- 2004-04-08 CL CL200400761A patent/CL2004000761A1/es unknown
- 2004-04-12 AR ARP040101209A patent/AR043845A1/es not_active Application Discontinuation
-
2005
- 2005-10-10 ZA ZA200508180A patent/ZA200508180B/en unknown
- 2005-10-11 CO CO05103899A patent/CO5640107A2/es not_active Application Discontinuation
- 2005-10-18 NO NO20054794A patent/NO20054794L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1615919B1 (de) | 2007-08-22 |
| CO5640107A2 (es) | 2006-05-31 |
| AR043845A1 (es) | 2005-08-17 |
| ES2291868T3 (es) | 2008-03-01 |
| RU2005135154A (ru) | 2006-06-27 |
| DE602004008447D1 (de) | 2007-10-04 |
| AU2004228193B2 (en) | 2009-07-23 |
| NO20054794L (no) | 2005-10-27 |
| CA2520852C (en) | 2011-10-11 |
| JP4426569B2 (ja) | 2010-03-03 |
| AU2004228193A1 (en) | 2004-10-21 |
| EP1615919A1 (de) | 2006-01-18 |
| ZA200508180B (en) | 2007-03-28 |
| KR100700422B1 (ko) | 2007-03-28 |
| US6872833B2 (en) | 2005-03-29 |
| JP2006522765A (ja) | 2006-10-05 |
| US20040204584A1 (en) | 2004-10-14 |
| KR20050111795A (ko) | 2005-11-28 |
| BRPI0409402A (pt) | 2006-04-25 |
| WO2004089949A1 (en) | 2004-10-21 |
| CL2004000761A1 (es) | 2005-02-04 |
| TW200427685A (en) | 2004-12-16 |
| DE602004008447T2 (de) | 2008-05-21 |
| CA2520852A1 (en) | 2004-10-21 |
| CN100447140C (zh) | 2008-12-31 |
| MXPA05011102A (es) | 2005-12-12 |
| CN1774437A (zh) | 2006-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004015724D1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
| DE602004024420D1 (de) | Chinazolinderivate als antitumormittel | |
| ATE360632T1 (de) | Substituierte 8'-pyri(mi)dinyl-dihydrospiro- (cycloalkylamin)-pyrimido(1,2a)pyrimidin-6- onderivate | |
| DK1594840T3 (da) | Piperidin-benzensulfonamid-derivater | |
| ATE482932T1 (de) | N-alkynyl-2-(substituierte aryloxy)alkylthioamide derivate als fungizide | |
| IS8180A (is) | Nýjar besímídasólafleiður | |
| ATE420066T1 (de) | Amidoacetonitrilderivate | |
| ATE352550T1 (de) | Chinazolinderivate | |
| NO20054291D0 (no) | Trimert makrosyklisk substituerte benzenderivater | |
| ATE452892T1 (de) | Substituierte 8-perfluoro-6,7,8,9- tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate | |
| IS8364A (is) | N-þíasól-2-ýl-bensamíð afleiður | |
| DE602004013746D1 (de) | Imidazol-4-yl-ethynyl-pyridin-derivate | |
| ATE306265T1 (de) | Benzothiazolderivate als adenosin-rezeptor- liganden | |
| DE602004021572D1 (de) | SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE | |
| HK1092469A1 (en) | Benzothiazole derivatives as adenosine receptor ligands | |
| ATE432077T1 (de) | 5-arylpyrimidine als anti-krebs-mittel | |
| DE602004009796D1 (de) | Imidazolderivate als glutamatrezeptorantagonisten | |
| ATE325123T1 (de) | Imidazoquinoline derivate als adenosine a3 rezeptor liganden | |
| ATE394372T1 (de) | G-lactamderivate als prostaglandinagonisten | |
| ATE449064T1 (de) | Amidoacetonitrilderivate | |
| ATE370947T1 (de) | 7-((1,4)dioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren liganden | |
| ATE338043T1 (de) | 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten | |
| DE60106974D1 (de) | Aminotriazolopyridinderivate als adenosinrezeptorliganden | |
| ATE427945T1 (de) | Imidazolderivate | |
| DE60328233D1 (de) | Sulfamatbenzothiophenderivate als steroidsulfataseinhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1615919 Country of ref document: EP |